175 related articles for article (PubMed ID: 10022299)
1. Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations.
Gollapudi BB; Stott WT; Yano BL; Bus JS
Toxicol Lett; 1998 Dec; 102-103():479-84. PubMed ID: 10022299
[TBL] [Abstract][Full Text] [Related]
2. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
3. Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays.
Schmezer P; Eckert C; Liegibel UM; Zelezny O; Klein RG
Mutat Res; 1998 Sep; 405(2):193-8. PubMed ID: 9748572
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
5. Neonatal mouse model: review of methods and results.
McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
[TBL] [Abstract][Full Text] [Related]
6. In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.
Contrera JF; DeGeorge JJ
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):71-80. PubMed ID: 9539006
[TBL] [Abstract][Full Text] [Related]
7. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
Ashby J; Paton D
Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
[TBL] [Abstract][Full Text] [Related]
8. A perspective on current and future uses of alternative models for carcinogenicity testing.
Goodman JI
Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554
[TBL] [Abstract][Full Text] [Related]
9. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo.
Shephard SE; Lutz WK; Schlatter C
Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
[TBL] [Abstract][Full Text] [Related]
11. Evaluation on carcinogenicity of chemicals using transgenic mice.
Mitsumori K
Toxicology; 2002 Dec; 181-182():241-4. PubMed ID: 12505318
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic events during the process of cell transformation induced by carcinogens (review).
Nguyen-Ba G; Vasseur P
Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
[TBL] [Abstract][Full Text] [Related]
13. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
Ashby J; Tennant RW
Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
15. The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.
Floyd E; Mann P; Long G; Ochoa R
Toxicol Pathol; 2002; 30(1):147-56. PubMed ID: 11890468
[TBL] [Abstract][Full Text] [Related]
16. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
17. The parallelogram approach in studies of genotoxic effects.
Anderson D; Sorsa M; Waters MD
Mutat Res; 1994; 313(2-3):101-15. PubMed ID: 7523897
[TBL] [Abstract][Full Text] [Related]
18. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.
Dass SB; Bucci TJ; Heflich RH; Casciano DA
Cancer Lett; 1999 Aug; 143(1):81-5. PubMed ID: 10465341
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
